Glycolipid entries from the LIPID MAPS Structure Database (LMSD).
Source | Last Updated |
---|---|
LIPID MAPS Proteome Database (LMSD) | June 16, 2024 |
Main Class | Sub Class | LM ID | Name | LipidBank ID ▲ | KEGG ID | PubChem CID | ChEBI ID | Exact Mass | Formula |
---|---|---|---|---|---|---|---|---|---|
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AR02 |
|
44260749 | 1603.918527 | C76H137N3O32 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AR03 |
|
44260750 | 1631.949827 | C78H141N3O32 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AR04 |
|
44260751 | 1659.981127 | C80H145N3O32 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AR05 |
|
44260752 | 1688.012427 | C82H149N3O32 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AR06 |
|
44260753 | 1716.043727 | C84H153N3O32 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AR07 |
|
44260754 | 1685.996777 | C82H147N3O32 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AR08 |
|
44260755 | 1714.028077 | C84H151N3O32 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AS00 |
|
||||||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AS01 |
|
44260756 | 1721.945137 | C80H143N3O36 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AS02 |
|
44260757 | 1749.976437 | C82H147N3O36 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AS03 |
|
44260758 | 1778.007737 | C84H151N3O36 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AS04 |
|
44260759 | 1806.039037 | C86H155N3O36 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AS05 |
|
44260760 | 1834.070337 | C88H159N3O36 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AS06 |
|
44260761 | 1862.101637 | C90H163N3O36 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AS07 |
|
44260762 | 1832.054687 | C88H157N3O36 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AS08 |
|
44260763 | 1860.085987 | C90H161N3O36 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AT00 |
|
||||||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AT01 |
|
44260764 | 1883.997962 | C86H153N3O41 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AT02 |
|
44260765 | 1912.029262 | C88H157N3O41 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AT03 |
|
44260766 | 1940.060562 | C90H161N3O41 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AT04 |
|
44260767 | 1968.091862 | C92H165N3O41 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AT05 |
|
44260768 | 1996.123162 | C94H169N3O41 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AT06 |
|
44260769 | 2024.154462 | C96H173N3O41 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AT07 |
|
44260770 | 1994.107512 | C94H167N3O41 | |||
Neutral glycosphingolipids | Galbeta1-3GlcNAcbeta1-3Galbeta1-4Glc- (Lacto series) | LMSP0504AT08 |
|
44260771 | 2022.138812 | C96H171N3O41 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024